ADORA2A and schizophrenia: Thus, A2AR antagonism may alleviate schizophrenia symptoms by two complementary mechanisms: acutely via inhibition of enhanced GDNF-driven striatal dopamine release and chronically via downregulation of striatal GDNF expression (Fig. 8).